HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Hsd17b13 knockout mice exhibited NAFLD despite normal body weight, overall body fat content, and glucose metabolism17, which is also consistent with the key features of NAFLD development in Gm4951 knockout mice (Fig. 3c–g).